Understanding Suboxone and Opioid Treatment Funding in Florida
Explore the details of Suboxone medication-assisted treatment, SAMHSA's State Targeted Response to the Opioid Crisis Grant in Florida, and SEFBHN's Opioid STR request for MAT services expansion. Learn about the requirements and implications for providers and clients in offering FDA-approved medications and ensuring informed decisions for long-term MAT usage.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Suboxone: Medication-Assisted- Treatment Dr. Marc Schlosser, MD,ABOM,FACOG Health Care District Palm Beach County SEFBHN CQI Meeting April 28, 2017
Opioid Treatment Funding Request SEFBHN CQI Meeting April 28, 2017
SAMHSAs State Targeted Response to the Opioid Crisis Grant (Opioid STR) The State of Florida will be receiving $27,150,403 through DCF/Substance Abuse and Mental Health office Some of the highlights from state proposal: $17.7 million Methadone and Buprenorphrine maintenance treatment $3.7 million Vivitrol $1.7 million naloxone kits $420,000 Life Skills Training in rural counties (Okeechobee)
SEFBHNs Opioid STR Request Expansion/implementation of Medicated Assisted Treatment (MAT) services & medication costs Peer Specialists to identify, recruit and retain clients immediately after an overdose reversal while they are still in the Emergency Room. Detox beds Addictions Receiving Facility Treatment Vouchers to increase treatment capacity with for-profit providers Prevention Training
Opioid STR Requirements The grant s intention is to expand services and access to medication assisted treatment (MAT), in combination with psychosocial interventions. Funds MAY NOT be expended by agencies that deny eligible individuals access to their programs because of their use of FDA-approved medications. Patients MUST BE ALLOWED to participate in treatment programs while utilizing FDA-approved MAT.
Opioid STR Requirements In all cases, MAT must be permitted to be continued for as long as the prescriber or treatment provider determines that the medication beneficial. Grantees must assure that clients will not be compelled to no longer use MAT as part of the conditions of any programming if stopping is inconsistent with a recommendation or valid prescription." is clinically licensed prescriber s
What does this mean? The provider would need to demonstrate that they are not compelling clients to taper off suboxone against a prescriber's recommendation. How would this be documented? Will the prescriber and the client be making a fully informed decision based on likely clinical outcomes? Or will this decision be influenced by the provider's philosophical opposition to agonist medications (methadone or buprenorphine)?
What can we do to prepare this funding? Update their policies and procedures to reflect the admission of MAT consumers into their programs. What are the barriers in your agency? How can SEFBHN help? What trainings, presentations, etc. would you like?
For more information, please contact: Linda Kane 561-203-2485, ext. 305 Linda.kane@sefbhn.org
